
US-based Synthego Corp. provides software solutions for biological research, primarily serving California.
synthego.comCrawled Oct 16, 2026
The blog covers alternatives to CRISPR-Cas9, including how alternative nucleases are used to create therapies.
The Bench Blog covers CRISPR news, updates, research, and gene-editing articles.
Rebecca Shapiro, an assistant professor at the University of Guelph, discusses using CRISPR to study disease-causing mechanisms in fungal pathogens. Her lab also studies gene drives and genetic interactions in fungi and develops approaches to treat fungal biofilms.
The weekly CRISPR news roundup discusses research on obesity, anti-cancer drug resistance, and fungal research.
The page provides contact information, news and press releases, and downloadable brand resources.
Synthego offers employees a welcome package, branded merchandise, and benefits.
Synthego is a CRISPR solutions company that enables the acceleration of life science research and development in the pursuit of improved human health.
The company answers finance questions about gRNA and nucleases. EditCo provides accounting assistance for orders of Engineered Cells, Gene Knockout Kits, and Arrayed Libraries.
The company provides information about its products and help using them in experiments.
The company provides ordering support for gRNA and nucleases. EditCo supports orders for Engineered Cells, Gene Knockout Kits, and Arrayed Libraries.
The company discusses how its products can support research and therapeutic development. EditCo provides information about Engineered Cells, Gene Knockout Kits, and Arrayed Libraries.
High-quality, scalable solutions for CRISPR research, molecular biology and diagnostic workflows.
GitHubRepository owner